scholarly article | Q13442814 |
P50 | author | Elio Riboli | Q28356166 |
Anne Zeleniuch-Jacquotte | Q28360434 | ||
Vittorio Krogh | Q28360446 | ||
Rudolf Kaaks | Q28360645 | ||
Göran Hallmans | Q28360648 | ||
Roy E Shore | Q37837423 | ||
Andrea Micheli | Q43258179 | ||
Per Lenner | Q78150231 | ||
Eva Lundin | Q78151119 | ||
P2093 | author name string | L Dossus | |
P Toniolo | |||
A Arslan | |||
S Rinaldi | |||
F Berrino | |||
K L Koenig | |||
A Lukanova | |||
P Muti | |||
P Stattin | |||
A Mure | |||
P433 | issue | 2 | |
P304 | page(s) | 161-171 | |
P577 | publication date | 2004-02-01 | |
P1433 | published in | European Journal of Endocrinology | Q3060778 |
P1476 | title | Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women | |
P478 | volume | 150 |
Q36541776 | A Comparative Analysis of Dietary Habits on Sensory Motor Association and Heart Rate Variability during Menstrual Cycle |
Q47418110 | A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC). |
Q34570111 | A pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones |
Q37980379 | A review of the relationships between extreme obesity, quality of life, and sexual function |
Q38323835 | Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study |
Q38283025 | Adipose tissue macrophages: the inflammatory link between obesity and cancer? |
Q38565775 | Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features |
Q36964832 | Androgens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion |
Q37452399 | Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender |
Q37694024 | Anthropometric measures and serum estrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study |
Q36928032 | Association of IGF1 with glycemic control and occurrence of severe hypoglycemia in patients with type 1 diabetes mellitus |
Q26740255 | Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition |
Q51154398 | Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women. |
Q36662479 | Associations of anthropometric measures on breast cancer risk in pre- and postmenopausal women--a case-control study |
Q37151431 | Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer |
Q59139451 | Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women |
Q37315693 | Bioactive insulin-like growth factor-I in obesity |
Q50131565 | Body Mass Index Effect on Differing Responses to Psychological Stress in Blood Glucose Dynamics in Patients With Type 1 Diabetes |
Q36579730 | Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study |
Q34625592 | Body mass index and its correlation to metabolic and hormone parameters in postmenopausal Spanish women. |
Q36298074 | Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis |
Q57054412 | Body mass index, waist circumference and waist–hip ratio and serum levels of IGF-I and IGFBP-3 in European women |
Q64074174 | Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model |
Q48283361 | Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts |
Q33821523 | Comparison of postmenopausal endogenous sex hormones among Japanese, Japanese Brazilians, and non-Japanese Brazilians |
Q33907889 | Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women |
Q35767673 | Cross-Sectional Associations between Body Size, Circulating Sex-Steroid Hormones and IGF Components among Healthy Chinese Women |
Q30370836 | Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men. |
Q35512365 | Determinants of maternal sex steroids during the first half of pregnancy |
Q38097984 | Diabetes and cancer relationships |
Q37951807 | Dietary, endocrine, and metabolic factors in the development of colorectal cancer. |
Q34198265 | Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies |
Q35234657 | Effect modification of obesity on associations between endogenous steroid sex hormones and arterial calcification in women at midlife |
Q92702894 | Effect of Inflammation on Female Gonadotropin-Releasing Hormone (GnRH) Neurons: Mechanisms and Consequences |
Q36216723 | Effects of chronic vs. intermittent calorie restriction on mammary tumor incidence and serum adiponectin and leptin levels in MMTV-TGF-α mice at different ages |
Q47406662 | Endogenous hormones, inflammation, and body size in premenopausal Mexican women: results from the Mexican Teachers' Cohort (MTC, ESMaestras). |
Q44354751 | Enhanced hypothalamic-pituitary sensitivity to estrogen in premenopausal women with diminished ovarian reserve compared with older perimenopausal controls |
Q52671211 | Estrogen Metabolism in Premenopausal Women Is Related to Early Life Body Fatness. |
Q92240915 | Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression |
Q37008462 | Exogenous and endogenous hormones and breast cancer |
Q35661787 | Exogenous estrogen as mediator of racial differences in bioactive insulin-like growth factor-I levels among postmenopausal women |
Q34257104 | Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort |
Q34522434 | Green and black tea in relation to gynecologic cancers |
Q34200821 | Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance |
Q46808772 | Human platelets differentially concentrate estradiol, estrone and testosterone. |
Q81158385 | Hyperandrogenism, mediated by obesity and receptor polymorphisms, promotes aggressive epithelial ovarian cancer biology |
Q36082076 | Hypertension in postmenopausal women |
Q46839458 | IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project |
Q48057093 | Increased mood symptoms in postmenopausal women related to the polymorphism rs743572 of the CYP17 A1 gene |
Q35680361 | Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort |
Q37417429 | Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women |
Q47939810 | Influence of obesity and hormone disturbances on sexuality of women in the menopause |
Q38883620 | Insulin, insulin receptors, and cancer. |
Q38110572 | Insulin-like growth factor-I (IGF-I) and clinical nutrition |
Q28740805 | Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer |
Q47212420 | Interactive effects of ovarian steroid hormones on alcohol use and binge drinking across the menstrual cycle |
Q47279238 | Is body size associated with ovarian cancer in southern Chinese women? |
Q36189328 | Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? |
Q92897339 | Linkage Between Obesity Leptin and Breast Cancer |
Q51355481 | Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease. |
Q34156642 | Mammographic density change with 1 year of aerobic exercise among postmenopausal women: a randomized controlled trial |
Q47432818 | Maternal serum concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-1 before and during pregnancy in relation to maternal body weight and composition and infant birth weight |
Q38117541 | Measurement of testosterone in human sexuality research: methodological considerations |
Q27022929 | Mechanisms linking excess adiposity and carcinogenesis promotion |
Q34345110 | Menopausal hormone therapy and risk of endometrial cancer |
Q47254405 | Metabolic syndrome, circulating RBP4, testosterone, and SHBG predict weight regain at 6 months after weight loss in men. |
Q37210759 | Minireview: Obesity and breast cancer: the estrogen connection |
Q89761376 | Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer |
Q33592804 | Morbidity and mortality associated with obesity |
Q36788273 | Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications. |
Q38788240 | Obesity and Ovarian Cancer |
Q50856725 | Obesity and Prostate Cancer. |
Q37546055 | Obesity and renal cell carcinoma: epidemiology, underlying mechanisms and management considerations |
Q28275528 | Obesity and reproductive hormone levels in the transition to menopause |
Q37690552 | Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression |
Q37080029 | Obesity in relation to lung cancer incidence in African American women |
Q61799036 | Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms |
Q50957755 | Obesity-associated Breast Cancer: Analysis of risk factors. |
Q38633355 | Obesity-associated cancer: an immunological perspective |
Q47144869 | Opinion of the Scientific Panel on contaminants in the food chain (CONTAM) related to hormone residues in bovine meat and meat products |
Q33699606 | Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones |
Q37783713 | Perspectives on concordant and discordant relations between insulin-like growth factor 1 (IGF1) and growth in fishes |
Q30841046 | Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps |
Q82322674 | Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI? |
Q26771021 | Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist |
Q43680757 | Postmenopausal hormone replacement therapy and risk of cholecystectomy: a prospective cohort study |
Q83918293 | Postmenopausal hypertension |
Q83222329 | Postmenopausal sex hormones in relation to body fat distribution |
Q46470131 | Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause. |
Q50305210 | Prenatal testosterone of progenitors could be involved in the etiology of both anorexia nervosa and autism spectrum disorders of their offspring |
Q39145391 | Prevalence and correlates of vaginal estrogenization in postmenopausal women in the United States. |
Q33624660 | Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3 |
Q33642057 | Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. |
Q51354639 | Relation with HOMA-IR and thyroid hormones in obese Turkish women with metabolic syndrome. |
Q33231816 | Relationship of fat mass and serum estradiol with lower extremity bone in persons with chronic spinal cord injury |
Q49345665 | Reproductive steroids and ADHD symptoms across the menstrual cycle. |
Q37997819 | Respiratory health in women: from menarche to menopause |
Q39664897 | Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma |
Q34940600 | Salivary sex hormone measurement in a national, population-based study of older adults |
Q30368909 | Sympathetic arousal increases a negative memory bias in young women with low sex hormone levels. |
Q31164239 | Symptoms in peri- and postmenopausal women in relation to testosterone concentrations: data from The Women's Health in the Lund Area (WHILA) study |
Q27002477 | Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis |
Q37678925 | Testosterone, SHBG and cardiovascular health in postmenopausal women. |
Q92528754 | The Effects of Adipocytes on the Regulation of Breast Cancer in the Tumor Microenvironment: An Update |
Q52324116 | The Impact of Obesity on Breast Cancer. |
Q33872842 | The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women |
Q34204763 | The association of reproductive and lifestyle factors with a score of multiple endogenous hormones |
Q47805182 | The influence of different calorie restriction protocols on serum pro-inflammatory cytokines, adipokines and IGF-I levels in female C57BL6 mice: short term and long term diet effects |
Q26862782 | The insulin-like growth factor system and nutritional assessment |
Q35834256 | The relationship between bilateral oophorectomy and plasma hormone levels in postmenopausal women |
Q37581227 | The role of oestrogens in the adaptation of islets to insulin resistance |
Q40110180 | The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema |
Q37691234 | Tissue-specificity and ethnic diversity in obesity-related risk of cancer may be explained by variability in insulin response and insulin signaling pathways |
Q35705253 | Vitamin D and breast cancer |
Q30418474 | Worsened outcome from middle cerebral artery occlusion in aged rats receiving 17β-estradiol |
Search more.